Ángel Brea

1.6k total citations
37 papers, 794 citations indexed

About

Ángel Brea is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ángel Brea has authored 37 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ángel Brea's work include Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Liver Disease Diagnosis and Treatment (8 papers). Ángel Brea is often cited by papers focused on Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Liver Disease Diagnosis and Treatment (8 papers). Ángel Brea collaborates with scholars based in Spain, Australia and Argentina. Ángel Brea's co-authors include Emilio Ros, J.L. Cordero, Eva Martin‐Solana, Daniel Mosquera, José Puzo, Jesús Millán, Xavier Pintó, Juan Pedro‐Botet, Juan F. Ascaso and Ángel Díaz Rodríguez and has published in prestigious journals such as PLoS ONE, Arteriosclerosis Thrombosis and Vascular Biology and The American Journal of Cardiology.

In The Last Decade

Ángel Brea

35 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ángel Brea Spain	12	462	373	249	208	110	37	794
Jieling Xiao Singapore	17	717 1.6×	299 0.8×	150 0.6×	142 0.7×	136 1.2×	41	952
Guotai Sheng China	16	478 1.0×	445 1.2×	138 0.6×	177 0.9×	86 0.8×	58	850
Mohamed H. Ahmed United Kingdom	11	338 0.7×	184 0.5×	92 0.4×	50 0.2×	72 0.7×	22	533
Yuan Xu China	19	352 0.8×	361 1.0×	133 0.5×	86 0.4×	71 0.6×	51	1.1k
Paolo Conca Italy	16	906 2.0×	352 0.9×	202 0.8×	135 0.6×	158 1.4×	37	1.2k
Agustín Domínguez‐Díez Spain	8	582 1.3×	287 0.8×	153 0.6×	95 0.5×	89 0.8×	12	786
Eunice Xiang Xuan Tan Singapore	13	744 1.6×	304 0.8×	158 0.6×	107 0.5×	138 1.3×	26	984
Mariko Hakoshima Japan	12	208 0.5×	268 0.7×	174 0.7×	66 0.3×	128 1.2×	44	795
Jian-Gao Fan China	4	915 2.0×	383 1.0×	157 0.6×	139 0.7×	200 1.8×	5	1.2k
Osamah Hussein Israel	12	163 0.4×	158 0.4×	170 0.7×	86 0.4×	52 0.5×	21	514

Countries citing papers authored by Ángel Brea

Since Specialization

Citations

This map shows the geographic impact of Ángel Brea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángel Brea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángel Brea more than expected).

Fields of papers citing papers by Ángel Brea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángel Brea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángel Brea. The network helps show where Ángel Brea may publish in the future.

Co-authorship network of co-authors of Ángel Brea

This figure shows the co-authorship network connecting the top 25 collaborators of Ángel Brea. A scholar is included among the top collaborators of Ángel Brea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángel Brea. Ángel Brea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brea, Ángel, et al.. (2022). Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study. Frontiers in Genetics. 13. 971651–971651.

Amigó, Núria, Emili Corbella, Carlos Brotons, et al.. (2021). Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study. Journal of Clinical Medicine. 10(7). 1379–1379. 5 indexed citations

Pedro‐Botet, Juan, Juan F. Ascaso, Ángel Brea, et al.. (2020). Triglicéridos, colesterol HDL y dislipidemia aterogénica en la guía europea para el control de las dislipidemias 2019. Clínica e Investigación en Arteriosclerosis. 32(5). 209–218. 3 indexed citations

Ascaso, Juan F., Jesús Millán, Antonio Hernández‐Mijares, et al.. (2020). Dislipidemia aterogénica 2019. Documento de consenso del Grupo de Dislipidemia Aterogénica de la Sociedad Española de Arteriosclerosis. Clínica e Investigación en Arteriosclerosis. 32(3). 120–125. 6 indexed citations

Brea, Ángel, Jesús Millán, Juan F. Ascaso, et al.. (2018). Los fibratos en la prevención primaria de la enfermedad cardiovascular. Comentarios a los resultados de una revisión sistemática de la Colaboración Cochrane. Clínica e Investigación en Arteriosclerosis. 30(4). 188–192. 1 indexed citations

Brea, Ángel, Jesús Millán, Juan F. Ascaso, et al.. (2018). Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration. Clínica e Investigación en Arteriosclerosis (English Edition). 30(4). 188–192. 4 indexed citations

Hernández‐Mijares, Antonio, Juan F. Ascaso, Ángel Brea, et al.. (2018). Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos. Clínica e Investigación en Arteriosclerosis. 31(2). 75–88. 6 indexed citations

Brea, Ángel, Xavier Pintó, Juan F. Ascaso, et al.. (2017). Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition). 29(4). 185–200. 5 indexed citations

Ascaso, Juan F., Jesús Millán, Antonio Hernández‐Mijares, et al.. (2017). Documento de consenso sobre el manejo de la dislipemia aterogénica de la Sociedad Española de Arteriosclerosis. Clínica e Investigación en Arteriosclerosis. 29(2). 86–91. 15 indexed citations

10.

Brea, Ángel, Jesús Millán, Juan F. Ascaso, et al.. (2016). Terapia con fibratos: uso racional del fenofibrato 2016. Resumen ejecutivo. Clínica e Investigación en Arteriosclerosis. 28(6). 295–301. 5 indexed citations

11.

Brea, Ángel, Xavier Pintó, Juan F. Ascaso, et al.. (2016). Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular. Clínica e Investigación en Arteriosclerosis. 29(3). 141–148. 7 indexed citations

12.

Pérez‐Calahorra, Sofía, Rosa M. Sánchez-Hernández, Núria Plana, et al.. (2016). Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients. The American Journal of Cardiology. 119(5). 742–748. 11 indexed citations

13.

Castro-Orós, Isabel de, Rosa Solà, Rosa M. Valls, et al.. (2016). Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine. PLoS ONE. 11(3). e0150785–e0150785. 18 indexed citations

14.

Millán, Jesús, Antonio Hernández‐Mijares, Juan F. Ascaso, et al.. (2016). La auténtica dimensión del colesterol-no-HDL: colesterol aterogénico. Clínica e Investigación en Arteriosclerosis. 28(6). 265–270. 10 indexed citations

15.

Solà, Rosa, Rosa M. Valls, José Puzo, et al.. (2014). Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial. PLoS ONE. 9(8). e101978–e101978. 50 indexed citations

16.

Brea, Ángel, et al.. (2013). Epidemiología de la enfermedad vascular cerebral en España. Clínica e Investigación en Arteriosclerosis. 25(5). 211–217. 40 indexed citations

17.

Brea, Ángel & José Puzo. (2012). Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology. 167(4). 1109–1117. 86 indexed citations

18.

Mata, Nelva, et al.. (2012). Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe. European Journal of Public Health. 24(2). 221–225. 17 indexed citations

19.

Brea, Ángel, Daniel Mosquera, José María Mostaza, et al.. (2011). Hipertrigliceridemia, esteatosis hepática y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis. 23(2). 72–77. 1 indexed citations

20.

Ambroggi, Marta, Ángel Brea, Alessandro Fulgenzi, et al.. (2004). Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.. PubMed. 8(6). 778–84. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact